TLR4 and neoplasm: To test this hypothesis, we created a unique in vitro model in which tumor cell lines of various origins (lung, prostate, kidney, breast) were repeatedly exposed to macrophages stimulated with the TLR4 ligand lipopolysaccharide (LPS), leading to the development of tumor cell sublines resistant to macrophage cytotoxicity (75).